Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.

Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV.

J Viral Hepat. 2011 Apr;18(4):262-70. doi: 10.1111/j.1365-2893.2010.01297.x.

PMID:
20456636
2.

Failure to diagnose recent hepatitis C virus infections in London injecting drug users.

Aarons E, Grant P, Soldan K, Luton P, Tang J, Tedder R.

J Med Virol. 2004 Aug;73(4):548-53.

PMID:
15221898
3.

Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.

Balogun MA, Murphy N, Nunn S, Grant A, Andrews NJ, Teo CG, Ramsay ME, Parry JV.

Epidemiol Infect. 2009 Jul;137(7):980-7. doi: 10.1017/S0950268808001660. Epub 2008 Dec 23.

PMID:
19102796
4.

Hepatitis C virus infection among a cohort of Victorian injecting drug users.

Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA.

Med J Aust. 1993 Aug 16;159(4):237-41.

PMID:
7692222
5.

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.

Aitken CK, Tracy SL, Revill P, Bharadwaj M, Bowden DS, Winter RJ, Hellard ME.

J Clin Virol. 2008 Apr;41(4):293-6. doi: 10.1016/j.jcv.2007.12.007. Epub 2008 Feb 1.

PMID:
18242125
6.

Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil.

Lopes CL, Teles SA, Espírito-Santo MP, Lampe E, Rodrigues FP, Motta-Castro AR, Marinho TA, Reis NR, Silva AM, Martins RM.

Rev Saude Publica. 2009 Aug;43 Suppl 1:43-50.

7.

Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.

Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF.

J Clin Virol. 2009 Mar;44(3):200-6. doi: 10.1016/j.jcv.2008.12.008. Epub 2009 Feb 4.

PMID:
19195927
8.

Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.

Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H.

J Med Virol. 2010 Aug;82(8):1355-63. doi: 10.1002/jmv.21787.

PMID:
20572071
9.

Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.

Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV.

Int J STD AIDS. 2005 Nov;16(11):749-54.

PMID:
16303071
10.

Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil.

Silva MB, Andrade TM, Silva LK, Rodart IF, Lopes GB, Carmo TM, Zarife MA, Dourado I, Reis MG.

Mem Inst Oswaldo Cruz. 2010 May;105(3):299-303.

11.

Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.

Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG; Cyprus IVDU Network, Kostrikis LG.

J Med Virol. 2010 Feb;82(2):263-70. doi: 10.1002/jmv.21690. Erratum in: J Med Virol. 2010 May;82(5):910-1.

PMID:
20029809
12.

Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil.

Novais AC, Lopes CL, Reis NR, Silva AM, Martins RM, Souto FJ.

Mem Inst Oswaldo Cruz. 2009 Sep;104(6):892-6.

13.

Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations.

Brant LJ, Ramsay ME, Balogun MA, Boxall E, Hale A, Hurrelle M, Kaluba L, Klapper P, Lewis D, Patel BC, Parry J, Irving WL.

J Viral Hepat. 2008 Dec;15(12):871-7. doi: 10.1111/j.1365-2893.2008.01009.x. Epub 2008 Jul 10.

PMID:
18637073
14.

Hepatitis C virus molecular epidemiology in Uzbekistan.

Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M.

J Med Virol. 2003 Mar;69(3):367-75.

PMID:
12526047
15.

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.

Micallef JM, Macdonald V, Jauncey M, Amin J, Rawlinson W, van Beek I, Kaldor JM, White PA, Dore GJ.

J Viral Hepat. 2007 Jun;14(6):413-8.

PMID:
17501762
16.

Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Matheï C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F.

Eur J Clin Microbiol Infect Dis. 2005 Aug;24(8):514-22.

PMID:
16133411
17.

Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.

Devi KhS, Brajachand N, Singh HL, Singh YM.

J Commun Dis. 2005 Mar;37(1):73-7.

PMID:
16637404
18.

Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?

Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R.

J Infect. 2000 Mar;40(2):176-83.

PMID:
10841096
19.

Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.

Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R.

Addiction. 2009 Nov;104(11):1881-90. doi: 10.1111/j.1360-0443.2009.02687.x. Epub 2009 Aug 27.

20.

Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.

Judd A, Hutchinson S, Wadd S, Hickman M, Taylor A, Jones S, Parry JV, Cameron S, Rhodes T, Ahmed S, Bird S, Fox R, Renton A, Stimson GV, Goldberg D.

J Viral Hepat. 2005 Nov;12(6):655-62.

PMID:
16255768
Items per page

Supplemental Content

Write to the Help Desk